ABOUT SAXENDA DOSAGES

Anaphylaxis and angioedema are already noted with other GLP-one receptor agonists. Use warning in a very affected individual which has a background of anaphylaxis or angioedema with another GLP-1 receptor agonist mainly because it is unidentified whether or not these individuals will likely be predisposed to those reactions with Saxenda.(The typica